A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users

被引:127
|
作者
Garfein, Richard S.
Golub, Elizabeth T.
Greenberg, Alan E.
Hagan, Holly
Hanson, Debra L.
Hudson, Sharon M.
Kapadia, Farzana
Latka, Mary H.
Ouellet, Lawrence.
Purcell, David W.
Strathdee, Steffanie A.
Thiede, Hanne
机构
[1] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Natl Res & Dev Inst, New York, NY USA
[4] Hlth Res Assoc, Los Angeles, CA USA
[5] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[6] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[7] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[8] Publ Hlth Seattle & King Cty, Seattle, WA USA
[9] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA
关键词
hepatitis C virus; HIV; injection drug use; peer education; randomized controlled trial; young adult;
D O I
10.1097/QAD.0b013e32823f9066
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). Design: We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. Results: The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.971, and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Conclusion: Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission. (C) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:1923 / 1932
页数:10
相关论文
共 50 条
  • [21] Acute hepatitis C virus infection in incarcerated injection drug users
    McGovern, Barbara H.
    Wurcel, Alysse
    Kim, Arthur Y.
    zur Wiesch, Julian Schulze
    Bica, Ioana
    Zaman, M. Tauheed
    Timm, Joerg
    Walker, Bruce D.
    Lauer, Georg M.
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (12) : 1663 - 1670
  • [22] Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention
    Seal, KH
    Edlin, BR
    Ochoa, KC
    Tulsky, JP
    Moss, AR
    Hahn, JA
    WESTERN JOURNAL OF MEDICINE, 2000, 172 (01): : 16 - 20
  • [23] Hepatitis C Virus Infection and Related Risk Factors among Injection Drug Users in Montenegro
    Bacak, Valerio
    Lausevic, Dragan
    Mugosa, Boban
    Vratnica, Zoran
    Terzic, Natasa
    EUROPEAN ADDICTION RESEARCH, 2013, 19 (02) : 68 - 73
  • [24] Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan
    Alaei, Arash
    Mishkin, Kathryn
    Karimov, Saifuddin
    Saidi, Dilshod
    Alaei, Kamiar
    HEPATITIS MONTHLY, 2018, 18 (03)
  • [25] Coinfection with HIV and hepatitis C virus in injection drug users and minority populations
    Strader, DB
    CLINICAL INFECTIOUS DISEASES, 2005, 41 : S7 - S13
  • [26] Medical management of HIV - Hepatitis C virus coinfection in injection drug users
    Khalsa, JH
    Kresina, T
    Sherman, K
    Vocci, F
    CLINICAL INFECTIOUS DISEASES, 2005, 41 : S1 - S6
  • [27] Delivering care to injection drug users coinfected with HIV and hepatitis C virus
    Taylor, LE
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S355 - S361
  • [28] Not all injection drug users are created equal: Heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia
    Kuniholm, Mark H.
    Aladashvili, Malvina
    Del Rio, Carlos
    Stvilia, Ketavan
    Gabelia, Nino
    Chitale, Rohit A.
    Tsertsvadze, Tengiz
    Nelson, Kenrad E.
    SUBSTANCE USE & MISUSE, 2008, 43 (10) : 1424 - 1437
  • [29] The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004
    Holtzman, Deborah
    Barry, Vaughn
    Ouellet, Lawrence J.
    Jarlais, Don C. Des
    Vlahov, David
    Golub, Elizabeth T.
    Hudson, Sharon M.
    Garfein, Richard S.
    PREVENTIVE MEDICINE, 2009, 49 (01) : 68 - 73
  • [30] Associations between prescription opioid injection and Hepatitis C virus among young injection drug users
    Lankenau, Stephen
    Kecojevic, Aleksandar
    Silva, Karol
    DRUGS-EDUCATION PREVENTION AND POLICY, 2015, 22 (01) : 35 - 42